Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
 1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
2 Acute myeloid leukemia 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
3 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
4 Adipocytokine signaling pathway 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
5 Adrenergic signaling in cardiomyocytes 💬
 1件: AGTR1 💬 Losartan potassium 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
6 Adrenergic signaling in cardiomyocytes 💬
 1件: AGTR1 💬 Losartan 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
7 African trypanosomiasis 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
8 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: AGTR1 💬 Losartan potassium 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
9 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: AGTR1 💬 Losartan 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
10 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
11 Alcoholic liver disease 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
12 Aldosterone synthesis and secretion 💬
 1件: AGTR1 💬 Losartan potassium 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
13 Aldosterone synthesis and secretion 💬
 1件: AGTR1 💬 Losartan 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
14 Allograft rejection 💬
 1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
15 Allograft rejection 💬
 1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
16 Allograft rejection 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
17 Alzheimer disease 💬
 3件: CHRM1, CHRM3, CHRM5 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
18 Alzheimer disease 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
19 Alzheimer disease 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
20 Amoebiasis 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
21 AMPK signaling pathway 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
22 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
23 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
24 Antigen processing and presentation 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
25 Apelin signaling pathway 💬
 1件: AGTR1 💬 Losartan potassium 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
26 Apelin signaling pathway 💬
 1件: AGTR1 💬 Losartan 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
27 Apelin signaling pathway 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
28 Apoptosis 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
29 Asthma 💬
 1件: FCER1A 💬 Omalizumab 💬 Omalizumab 7件: 46, 53, 65, 98, 162, 226, 299 💬
30 Asthma 💬
 1件: IL13 💬 Cendakimab 💬 Cendakimab 1件: 98 💬
31 Asthma 💬
 1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
32 Asthma 💬
 1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
33 Asthma 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
34 Autoimmune thyroid disease 💬
 1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
35 Autoimmune thyroid disease 💬
 1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
36 Autophagy - animal 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
37 Autophagy - other 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
38 Breast cancer 💬
 1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
39 Breast cancer 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
40 C-type lectin receptor signaling pathway 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
41 Cadherin signaling 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
42 Calcium signaling pathway 💬
 1件: AGTR1 💬 Losartan potassium 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
43 Calcium signaling pathway 💬
 1件: AGTR1 💬 Losartan 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
44 Calcium signaling pathway 💬
 4件: CHRM1, CHRM2, CHRM3, CHRM5 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
45 Calcium signaling pathway 💬
 1件: CYSLTR1 💬 Montelukast sodium 💬 Montelukast 10件:  6 , 13, 19, 46, 61, 63, 85, 98, 222, 228 💬
46 Calcium signaling pathway 💬
 1件: CYSLTR1 💬 Montelukast 💬 Montelukast 10件:  6 , 13, 19, 46, 61, 63, 85, 98, 222, 228 💬
47 Calcium signaling pathway 💬
 1件: HRH1 💬 Loratadine 💬 Loratadine 5件: 13, 19, 46, 89, 98 💬
48 Calcium signaling pathway 💬
 1件: HRH2 💬 Famotidine 💬 Famotidine 7件:  6 , 46, 86, 98, 107, 145, 300 💬
49 cAMP signaling pathway 💬
 2件: CHRM1, CHRM2 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
50 Cellular senescence 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
51 Central carbon metabolism in cancer 💬
 1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
52 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
53 cGMP-PKG signaling pathway 💬
 1件: AGTR1 💬 Losartan potassium 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
54 cGMP-PKG signaling pathway 💬
 1件: AGTR1 💬 Losartan 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
55 Chagas disease 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
56 Chemical carcinogenesis - receptor activation 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
57 Choline metabolism in cancer 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
58 Cholinergic synapse 💬
 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
59 Collecting duct acid secretion 💬
 2件: ATP4A, ATP4B 💬 Dexlansoprazole 💬 Dexlansoprazole 1件: 98 💬
60 Collecting duct acid secretion 💬
 2件: ATP4A, ATP4B 💬 Dexlansoprazole sesquihydrate 💬 Dexlansoprazole 1件: 98 💬
61 Collecting duct acid secretion 💬
 2件: ATP4A, ATP4B 💬 Esomeprazole magnesium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
62 Collecting duct acid secretion 💬
 2件: ATP4A, ATP4B 💬 Esomeprazole sodium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
63 Collecting duct acid secretion 💬
 2件: ATP4A, ATP4B 💬 Esomeprazole 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
64 Collecting duct acid secretion 💬
 2件: ATP4A, ATP4B 💬 Esomeprazole strontium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
65 Collecting duct acid secretion 💬
 2件: ATP4A, ATP4B 💬 Esomeprazole magnesium dihydrate 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
66 Collecting duct acid secretion 💬
 2件: ATP4A, ATP4B 💬 Lansoprazole 💬 Lansoprazole 8件: 63, 71, 85, 98, 166, 222, 223, 299 💬
67 Collecting duct acid secretion 💬
 2件: ATP4A, ATP4B 💬 Omeprazole 💬 Omeprazole 18件:  6 ,  8 , 13, 21, 46, 51, 67, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
68 Collecting duct acid secretion 💬
 2件: ATP4A, ATP4B 💬 Omeprazole sodium 💬 Omeprazole 18件:  6 ,  8 , 13, 21, 46, 51, 67, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
69 Collecting duct acid secretion 💬
 2件: ATP4A, ATP4B 💬 Omeprazole magnesium 💬 Omeprazole 18件:  6 ,  8 , 13, 21, 46, 51, 67, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
70 Collecting duct acid secretion 💬
 2件: ATP4A, ATP4B 💬 Vonoprazan 💬 Vonoprazan 3件: 63, 97, 98 💬
71 Colorectal cancer 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
72 Coronavirus disease 💬
 1件: AGTR1 💬 Losartan potassium 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
73 Coronavirus disease 💬
 1件: AGTR1 💬 Losartan 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
74 Coronavirus disease 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
75 Coronavirus disease 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
76 Coronavirus disease 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
77 Coronavirus disease 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
78 Cortisol synthesis and secretion 💬
 1件: AGTR1 💬 Losartan potassium 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
79 Cortisol synthesis and secretion 💬
 1件: AGTR1 💬 Losartan 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
80 Cushing syndrome 💬
 1件: AGTR1 💬 Losartan potassium 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
81 Cushing syndrome 💬
 1件: AGTR1 💬 Losartan 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
82 Cytokine-cytokine receptor interaction 💬
 1件: CRLF2 💬 Solrikitug 💬 Solrikitug 1件: 98 💬
83 Cytokine-cytokine receptor interaction 💬
 1件: IL13 💬 Cendakimab 💬 Cendakimab 1件: 98 💬
84 Cytokine-cytokine receptor interaction 💬
 1件: IL4R 💬 Dupilumab 💬 Dupilumab 8件: 51, 97, 98, 160, 162, 222, 300, 306 💬
85 Cytokine-cytokine receptor interaction 💬
 1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
86 Cytokine-cytokine receptor interaction 💬
 1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
87 Cytokine-cytokine receptor interaction 💬
 1件: IL5RA 💬 Benralizumab 💬 Benralizumab 5件: 44, 45, 98, 162, 299 💬
88 Cytokine-cytokine receptor interaction 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
89 Cytokine-cytokine receptor interaction 💬
 1件: TSLP 💬 Tezepelumab 💬 Tezepelumab 3件: 44, 45, 98 💬
90 Diabetic cardiomyopathy 💬
 1件: AGTR1 💬 Losartan potassium 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
91 Diabetic cardiomyopathy 💬
 1件: AGTR1 💬 Losartan 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
92 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
93 Dilated cardiomyopathy 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
94 Efferocytosis 💬
 1件: S1PR1 💬 Etrasimod 💬 Etrasimod 3件: 96, 97, 98 💬
95 Efferocytosis 💬
 1件: S1PR1 💬 Etrasimod arginine 💬 Etrasimod 3件: 96, 97, 98 💬
96 Epstein-Barr virus infection 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
97 Epstein-Barr virus infection 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
98 Epstein-Barr virus infection 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
99 Epstein-Barr virus infection 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
100 ErbB signaling pathway 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
101 Fc epsilon RI signaling pathway 💬
 1件: FCER1A 💬 Omalizumab 💬 Omalizumab 7件: 46, 53, 65, 98, 162, 226, 299 💬
102 Fc epsilon RI signaling pathway 💬
 1件: IL13 💬 Cendakimab 💬 Cendakimab 1件: 98 💬
103 Fc epsilon RI signaling pathway 💬
 1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
104 Fc epsilon RI signaling pathway 💬
 1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
105 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
106 Fluid shear stress and atherosclerosis 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
107 FoxO signaling pathway 💬
 2件: S1PR1, S1PR4 💬 Etrasimod 💬 Etrasimod 3件: 96, 97, 98 💬
108 FoxO signaling pathway 💬
 2件: S1PR1, S1PR4 💬 Etrasimod arginine 💬 Etrasimod 3件: 96, 97, 98 💬
109 GABAergic synapse 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
110 Gastric acid secretion 💬
 2件: ATP4A, ATP4B 💬 Dexlansoprazole 💬 Dexlansoprazole 1件: 98 💬
111 Gastric acid secretion 💬
 2件: ATP4A, ATP4B 💬 Dexlansoprazole sesquihydrate 💬 Dexlansoprazole 1件: 98 💬
112 Gastric acid secretion 💬
 2件: ATP4A, ATP4B 💬 Esomeprazole magnesium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
113 Gastric acid secretion 💬
 2件: ATP4A, ATP4B 💬 Esomeprazole sodium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
114 Gastric acid secretion 💬
 2件: ATP4A, ATP4B 💬 Esomeprazole 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
115 Gastric acid secretion 💬
 2件: ATP4A, ATP4B 💬 Esomeprazole strontium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
116 Gastric acid secretion 💬
 2件: ATP4A, ATP4B 💬 Esomeprazole magnesium dihydrate 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
117 Gastric acid secretion 💬
 2件: ATP4A, ATP4B 💬 Lansoprazole 💬 Lansoprazole 8件: 63, 71, 85, 98, 166, 222, 223, 299 💬
118 Gastric acid secretion 💬
 2件: ATP4A, ATP4B 💬 Omeprazole 💬 Omeprazole 18件:  6 ,  8 , 13, 21, 46, 51, 67, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
119 Gastric acid secretion 💬
 2件: ATP4A, ATP4B 💬 Omeprazole sodium 💬 Omeprazole 18件:  6 ,  8 , 13, 21, 46, 51, 67, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
120 Gastric acid secretion 💬
 2件: ATP4A, ATP4B 💬 Omeprazole magnesium 💬 Omeprazole 18件:  6 ,  8 , 13, 21, 46, 51, 67, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
121 Gastric acid secretion 💬
 2件: ATP4A, ATP4B 💬 Vonoprazan 💬 Vonoprazan 3件: 63, 97, 98 💬
122 Gastric acid secretion 💬
 1件: CHRM3 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
123 Gastric acid secretion 💬
 1件: HRH2 💬 Famotidine 💬 Famotidine 7件:  6 , 46, 86, 98, 107, 145, 300 💬
124 Gastric cancer 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
125 Glioma 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
126 Graft-versus-host disease 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
127 Growth hormone synthesis, secretion and action 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
128 Hematopoietic cell lineage 💬
 1件: IL4R 💬 Dupilumab 💬 Dupilumab 8件: 51, 97, 98, 160, 162, 222, 300, 306 💬
129 Hematopoietic cell lineage 💬
 1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
130 Hematopoietic cell lineage 💬
 1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
131 Hematopoietic cell lineage 💬
 1件: IL5RA 💬 Benralizumab 💬 Benralizumab 5件: 44, 45, 98, 162, 299 💬
132 Hematopoietic cell lineage 💬
 1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
133 Hematopoietic cell lineage 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
134 Hepatitis B 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
135 Hepatitis B 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
136 Hepatitis B 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
137 Hepatitis B 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
138 Hepatitis C 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
139 Hepatitis C 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
140 Hepatitis C 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
141 Hepatitis C 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
142 Hepatocellular carcinoma 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
143 Herpes simplex virus 1 infection 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
144 Herpes simplex virus 1 infection 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
145 Herpes simplex virus 1 infection 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
146 Herpes simplex virus 1 infection 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
147 Herpes simplex virus 1 infection 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
148 HIF-1 signaling pathway 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
149 Hormone signaling 💬
 1件: AGTR1 💬 Losartan potassium 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
150 Hormone signaling 💬
 1件: AGTR1 💬 Losartan 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
151 Human cytomegalovirus infection 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
152 Human cytomegalovirus infection 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
153 Human cytomegalovirus infection 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
154 Human cytomegalovirus infection 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
155 Human cytomegalovirus infection 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
156 Human immunodeficiency virus 1 infection 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
157 Human immunodeficiency virus 1 infection 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
158 Human papillomavirus infection 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
159 Human papillomavirus infection 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
160 Human papillomavirus infection 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
161 Human papillomavirus infection 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
162 Human papillomavirus infection 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
163 Human T-cell leukemia virus 1 infection 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
164 Human T-cell leukemia virus 1 infection 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
165 Human T-cell leukemia virus 1 infection 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
166 Human T-cell leukemia virus 1 infection 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
167 Huntington disease 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
168 Hypertrophic cardiomyopathy 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
169 IL-17 signaling pathway 💬
 1件: IL13 💬 Cendakimab 💬 Cendakimab 1件: 98 💬
170 IL-17 signaling pathway 💬
 1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
171 IL-17 signaling pathway 💬
 1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
172 IL-17 signaling pathway 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
173 Inflammatory bowel disease 💬
 1件: IL13 💬 Cendakimab 💬 Cendakimab 1件: 98 💬
174 Inflammatory bowel disease 💬
 1件: IL4R 💬 Dupilumab 💬 Dupilumab 8件: 51, 97, 98, 160, 162, 222, 300, 306 💬
175 Inflammatory bowel disease 💬
 1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
176 Inflammatory bowel disease 💬
 1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
177 Inflammatory bowel disease 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
178 Inflammatory mediator regulation of TRP channels 💬
 1件: HRH1 💬 Loratadine 💬 Loratadine 5件: 13, 19, 46, 89, 98 💬
179 Influenza A 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
180 Influenza A 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
181 Influenza A 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
182 Influenza A 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
183 Insulin resistance 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
184 Insulin resistance 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
185 Insulin secretion 💬
 1件: CHRM3 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
186 Insulin signaling pathway 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
187 Integrated stress response (ISR) signaling pathway 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
188 Integrin signaling 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
189 Intestinal immune network for IgA production 💬
 1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
190 Intestinal immune network for IgA production 💬
 1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
191 JAK-STAT signaling pathway 💬
 1件: CRLF2 💬 Solrikitug 💬 Solrikitug 1件: 98 💬
192 JAK-STAT signaling pathway 💬
 1件: IL13 💬 Cendakimab 💬 Cendakimab 1件: 98 💬
193 JAK-STAT signaling pathway 💬
 1件: IL4R 💬 Dupilumab 💬 Dupilumab 8件: 51, 97, 98, 160, 162, 222, 300, 306 💬
194 JAK-STAT signaling pathway 💬
 1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
195 JAK-STAT signaling pathway 💬
 1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
196 JAK-STAT signaling pathway 💬
 1件: IL5RA 💬 Benralizumab 💬 Benralizumab 5件: 44, 45, 98, 162, 299 💬
197 JAK-STAT signaling pathway 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
198 JAK-STAT signaling pathway 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
199 JAK-STAT signaling pathway 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
200 JAK-STAT signaling pathway 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
201 JAK-STAT signaling pathway 💬
 1件: TSLP 💬 Tezepelumab 💬 Tezepelumab 3件: 44, 45, 98 💬
202 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
203 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
204 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
205 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
206 Legionellosis 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
207 Leishmaniasis 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
208 Leishmaniasis 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
209 Leishmaniasis 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
210 Leishmaniasis 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
211 Lipid and atherosclerosis 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
212 Longevity regulating pathway 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
213 Longevity regulating pathway - multiple species 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
214 Lysosome biogenesis 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
215 Malaria 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
216 MAPK signaling pathway 💬
 1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
217 MAPK signaling pathway 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
218 Measles 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
219 Measles 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
220 Measles 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
221 Melanogenesis 💬
 1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
222 MicroRNAs in cancer 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
223 Morphine addiction 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
224 mTOR signaling pathway 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
225 mTOR signaling pathway 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
226 Natural killer cell mediated cytotoxicity 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
227 Necroptosis 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
228 Necroptosis 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
229 Necroptosis 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
230 Necroptosis 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
231 Neuroactive ligand signaling 💬
 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
232 Neuroactive ligand signaling 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
233 Neuroactive ligand signaling 💬
 1件: HRH1 💬 Loratadine 💬 Loratadine 5件: 13, 19, 46, 89, 98 💬
234 Neuroactive ligand signaling 💬
 1件: HRH2 💬 Famotidine 💬 Famotidine 7件:  6 , 46, 86, 98, 107, 145, 300 💬
235 Neuroactive ligand signaling 💬
 5件: HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 Ondansetron 💬 Ondansetron 5件:  6 , 97, 98, 107, 231 💬
236 Neuroactive ligand signaling 💬
 5件: HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 Ondansetron hydrochloride hydrate 💬 Ondansetron 5件:  6 , 97, 98, 107, 231 💬
237 Neuroactive ligand signaling 💬
 1件: SLC6A4 💬 Citalopram hydrobromide 💬 Citalopram 7件:  6 ,  8 , 13, 18, 46, 98, 127 💬
238 Neuroactive ligand signaling 💬
 1件: SLC6A4 💬 Citalopram 💬 Citalopram 7件:  6 ,  8 , 13, 18, 46, 98, 127 💬
239 Neuroactive ligand-receptor interaction 💬
 1件: AGTR1 💬 Losartan potassium 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
240 Neuroactive ligand-receptor interaction 💬
 1件: AGTR1 💬 Losartan 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
241 Neuroactive ligand-receptor interaction 💬
 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
242 Neuroactive ligand-receptor interaction 💬
 1件: CYSLTR1 💬 Montelukast sodium 💬 Montelukast 10件:  6 , 13, 19, 46, 61, 63, 85, 98, 222, 228 💬
243 Neuroactive ligand-receptor interaction 💬
 1件: CYSLTR1 💬 Montelukast 💬 Montelukast 10件:  6 , 13, 19, 46, 61, 63, 85, 98, 222, 228 💬
244 Neuroactive ligand-receptor interaction 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
245 Neuroactive ligand-receptor interaction 💬
 1件: HRH1 💬 Loratadine 💬 Loratadine 5件: 13, 19, 46, 89, 98 💬
246 Neuroactive ligand-receptor interaction 💬
 1件: HRH2 💬 Famotidine 💬 Famotidine 7件:  6 , 46, 86, 98, 107, 145, 300 💬
247 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 Beclomethasone dipropionate 💬 Beclomethasone dipropionate 2件: 97, 98 💬
248 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 Beclometasone 💬 Beclomethasone dipropionate 2件: 97, 98 💬
249 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 Beclomethasone dipropionate monohydrate 💬 Beclomethasone dipropionate 2件: 97, 98 💬
250 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 Budesonide 💬 Budesonide 10件: 66, 93, 94, 95, 96, 97, 98, 223, 228, 299 💬
251 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 Fluticasone 💬 Fluticasone 4件: 98, 228, 299, 306 💬
252 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 Fluticasone propionate 💬 Fluticasone propionate 3件: 98, 228, 306 💬
253 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 Mometasone 💬 Mometasone 2件: 98, 162 💬
254 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 Mometasone furoate 💬 Mometasone furoate 2件: 98, 162 💬
255 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 Mometasone furoate hydrate 💬 Mometasone furoate 2件: 98, 162 💬
256 Neuroactive ligand-receptor interaction 💬
 3件: S1PR1, S1PR4, S1PR5 💬 Etrasimod 💬 Etrasimod 3件: 96, 97, 98 💬
257 Neuroactive ligand-receptor interaction 💬
 3件: S1PR1, S1PR4, S1PR5 💬 Etrasimod arginine 💬 Etrasimod 3件: 96, 97, 98 💬
258 Neutrophil extracellular trap formation 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
259 NF-kappa B signaling pathway 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
260 Nicotine addiction 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
261 NOD-like receptor signaling pathway 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
262 NOD-like receptor signaling pathway 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
263 NOD-like receptor signaling pathway 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
264 NOD-like receptor signaling pathway 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
265 Non-alcoholic fatty liver disease 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
266 Osteoclast differentiation 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
267 Osteoclast differentiation 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
268 Osteoclast differentiation 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
269 Osteoclast differentiation 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
270 Oxidative phosphorylation 💬
 2件: ATP4A, ATP4B 💬 Dexlansoprazole 💬 Dexlansoprazole 1件: 98 💬
271 Oxidative phosphorylation 💬
 2件: ATP4A, ATP4B 💬 Dexlansoprazole sesquihydrate 💬 Dexlansoprazole 1件: 98 💬
272 Oxidative phosphorylation 💬
 2件: ATP4A, ATP4B 💬 Esomeprazole magnesium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
273 Oxidative phosphorylation 💬
 2件: ATP4A, ATP4B 💬 Esomeprazole sodium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
274 Oxidative phosphorylation 💬
 2件: ATP4A, ATP4B 💬 Esomeprazole 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
275 Oxidative phosphorylation 💬
 2件: ATP4A, ATP4B 💬 Esomeprazole strontium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
276 Oxidative phosphorylation 💬
 2件: ATP4A, ATP4B 💬 Esomeprazole magnesium dihydrate 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
277 Oxidative phosphorylation 💬
 2件: ATP4A, ATP4B 💬 Lansoprazole 💬 Lansoprazole 8件: 63, 71, 85, 98, 166, 222, 223, 299 💬
278 Oxidative phosphorylation 💬
 2件: ATP4A, ATP4B 💬 Omeprazole 💬 Omeprazole 18件:  6 ,  8 , 13, 21, 46, 51, 67, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
279 Oxidative phosphorylation 💬
 2件: ATP4A, ATP4B 💬 Omeprazole sodium 💬 Omeprazole 18件:  6 ,  8 , 13, 21, 46, 51, 67, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
280 Oxidative phosphorylation 💬
 2件: ATP4A, ATP4B 💬 Omeprazole magnesium 💬 Omeprazole 18件:  6 ,  8 , 13, 21, 46, 51, 67, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
281 Oxidative phosphorylation 💬
 2件: ATP4A, ATP4B 💬 Vonoprazan 💬 Vonoprazan 3件: 63, 97, 98 💬
282 Pancreatic cancer 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
283 Pancreatic cancer 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
284 Pancreatic cancer 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
285 Pancreatic cancer 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
286 Pancreatic secretion 💬
 1件: CHRM3 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
287 Pathogenic Escherichia coli infection 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
288 Pathways in cancer 💬
 1件: AGTR1 💬 Losartan potassium 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
289 Pathways in cancer 💬
 1件: AGTR1 💬 Losartan 💬 Losartan 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
290 Pathways in cancer 💬
 1件: IL13 💬 Cendakimab 💬 Cendakimab 1件: 98 💬
291 Pathways in cancer 💬
 1件: IL4R 💬 Dupilumab 💬 Dupilumab 8件: 51, 97, 98, 160, 162, 222, 300, 306 💬
292 Pathways in cancer 💬
 1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
293 Pathways in cancer 💬
 1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
294 Pathways in cancer 💬
 1件: IL5RA 💬 Benralizumab 💬 Benralizumab 5件: 44, 45, 98, 162, 299 💬
295 Pathways in cancer 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
296 Pathways in cancer 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
297 Pathways in cancer 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
298 Pathways in cancer 💬
 1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
299 Pathways in cancer 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
300 Pathways of neurodegeneration - multiple diseases 💬
 3件: CHRM1, CHRM3, CHRM5 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
301 Pathways of neurodegeneration - multiple diseases 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬